Status:
UNKNOWN
The Clinical Effect of Pregabalin on Neuropathic Pain in Non Central Sensitized Patients After Total Knee Arthroplasty
Lead Sponsor:
The Catholic University of Korea
Conditions:
Osteoarthritis
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
In this study, patients scheduled to undergo total knee arthroplasty (TKA) will be screened through a survey for patients without central sensitivity and patients with neuropathic pain as preoperative...
Detailed Description
Screening for central sensitization and neuropathic pain will be performed two weeks in advance of surgery for patients scheduled to undergo total knee arthroplasty, and is performed through a central...
Eligibility Criteria
Inclusion
- Patients for total knee arthroplasty over the age of 19
- Patients who have the will or ability to follow the doctor's instructions, including rehabilitation treatment such as joint exercise.
- Patients understand this study and agree in writing by the patient's own or by the patient's representative to participate in the study.
- Patients with non central sensitization and neuropathic pain.
Exclusion
- Rheumatoid arthritis
- Other inflammatory arthritis
- Neuropsychiatric patients
- Hepatic insufficiency
- Renal insufficiency
- Allergy or intolerance to study medications
- Patients with an acetylsalicylic acid of IV (angina, congestive heart failure, dementia, cerebrovascular accident)
- Chronic gabapentin or pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (taking opioids for longer than 3 months)
- Alcohol, drug abuser
- Narcotics addiction
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05322681
Start Date
May 1 2022
End Date
May 1 2023
Last Update
April 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Catholic Univerisity of Korea Seoul St Mary's hospital
Seoul, South Korea